CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Mike Grey will be speaking on a panel, Driving Life Sciences Discovery in 2011 and Beyond: Acquire or Partner? at BIOCOMS May breakfast meeting, San Diego CA.
News | 05. 04. 2011
